L&T Wins Amaravati Twin-Tower Project Near Quantum Computing Centre

 

ANDHRA PRADESH  /  INFRASTRUCTURE & DEEP TECH

The Andhra Pradesh order covers two proposed 47-floor office towers with a combined built-up area of 37.5 lakh sq. ft. The contract value was not disclosed separately.

Amaravati Quantum Valley presentation visual supplied by Biz Masala; an illustration, not a photograph of a completed project.

AMARAVATI, October 21, 2026 — Larsen & Toubro (L&T) has secured an order from the Government of Andhra Pradesh to build two office towers beside the Amaravati Quantum Computing Centre, adding a major construction project to the state capital’s planned technology district.

The towers are planned on either side of the centre. Each is configured with a basement, ground floor and 47 upper floors, and together they will cover 37.5 lakh square feet, L&T said in its announcement.

The company did not disclose the value of the Andhra Pradesh contract separately. L&T described its latest wins as “large orders,” a category covering more than one project in the announcement. That combined classification should not be treated as the Amaravati project’s value alone.

Architectural rendering of a tower supplied by Biz Masala; illustrative and not independently confirmed as the final design.

Offices planned alongside quantum infrastructure

The towers are part of the broader development around Amaravati’s Quantum Computing Centre. Andhra Pradesh has been working with industry partners to establish a quantum technology hub in the capital, with the centre intended to anchor research and technology activity.

L&T’s announcement confirms the towers’ location, configuration and combined built-up area. It does not specify prospective occupants or a tenant pipeline. The project’s eventual economic impact will depend on construction delivery and on whether research organisations, technology companies and other businesses establish operations there.

Quantum-computing equipment image supplied by Biz Masala for illustration; it is not identified as the system selected for Amaravati.

Aerial view supplied by Biz Masala; its location and connection to this specific project have not been independently verified.

What the announcement confirms

Project detail

Confirmed information

Client

Government of Andhra Pradesh

Location

Amaravati, beside the Amaravati Quantum Computing Centre

Number of towers

Two

Configuration

Basement + ground + 47 floors each

Combined built-up area

37.5 lakh sq. ft.

Separate contract value

Not disclosed by L&T

A construction milestone, with execution still ahead

The project links large-scale commercial construction with the state’s plans for a quantum technology ecosystem. But a construction order is an infrastructure milestone, not proof that a fully operating technology cluster or a specific number of jobs has already been created.

For Amaravati, the next indicators to watch are construction progress, the quantum centre’s readiness, and announcements about research, technology and office-space users. Those details will help show whether the twin towers become part of an active innovation district.

SOURCES

L&T announcement, October 21, 2026: https://www.larsentoubro.com/pressreleases/2026/2026-10-21-lt-wins-orders-large-in-new-delhi-and-andhra-pradesh

Government of Andhra Pradesh order on Amaravati Quantum Computing Centre: https://crda.ap.gov.in/APCRDADOCS/GOSACTSRULES/Capital%20City/01~17232026MAUD_RT21_E.pdf

Comments

Post a Comment

Popular posts from this blog

THE GREAT INDIAN CINEMA RESET

Image
  BIZ MASALA | BUSINESS. MARKETS. PEOPLE. INSIGHT. From Bollywood's dominance to the pan-India blockbuster: how regional cinema, streaming and changing audience behaviour rewrote the business of Indian films By Murthy ASR | Biz Masala | 17 October 2026 Hero artwork created for this story; conceptual illustration, not a documentary photograph. The opening scene: A business no longer controlled by one city For decades, Mumbai occupied the commanding heights of Indian cinema. Hindi films enjoyed cultural and commercial reach, while Telugu, Tamil, Malayalam and Kannada cinema had powerful home markets but more limited national distribution. S. S. Rajamouli's Baahubali: The Beginning (2015) helped demonstrate that a film rooted in one linguistic industry could travel nationally when storytelling, scale, marketing and distribution worked together. Baahubali 2 and later successes from Telugu and Kannada cinema reinforced the lesson. A decade later, dubbed releases are ...
Read more

SINGARENI COAL PUZZLE : THE CONTRACT QUESTION

Image
  What the CAG found in Singareni’s coal operations—and what remains to be answered By Murthy ASR   |   Biz Masala Investigative Series The audit trail is public. The follow-through is the next question. Singareni Collieries Company Limited (SCCL) is jointly owned by the Governments of Telangana (51%) and India (49%). It is not simply a mining company: its coal feeds power generation and industry, and its operating decisions have consequences for workers, consumers and public finances. A subject-specific compliance audit by the Comptroller and Auditor General of India (CAG), covering overburden removal, coal transportation and stowing-material contracts during 2018–19 to 2022–23, put several contract-design and operational questions on the public record. The report was tabled in the Telangana legislature on 30 March 2026. Its findings are historical and specific to the contracts and periods examined; they do not, by themselves, establish the cause of later pro...
Read more

WHO TESTS THE MEDICINES INDIA MAKES?

Image
  BIZ MASALA SIGNATURE STORY Inside the business of pharmaceutical testing laboratories — the money, the market and the science behind a medicine’s quality By Murthy ASR   |   18 October 2026 Illustrative editorial image: pharmaceutical analytical testing laboratory. A medicine may be manufactured on a modern production line, packed in a clean facility and shipped across the world. But before a batch can be trusted, its quality has to be demonstrated. Behind that assurance is a less visible industry: laboratories that test ingredients, finished formulations, impurities, stability and, where relevant, biological characteristics. For India, this is more than a technical service. The country’s pharmaceutical manufacturers supply domestic patients and regulated markets overseas. Their products must meet specifications, documentation requirements and regulatory expectations that vary by medicine and destination. Testing laboratories help generate the evidence on ...
Read more